A detailed history of Commonwealth Equity Services, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 65,463 shares of HUMA stock, worth $349,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,463
Previous 29,116 124.84%
Holding current value
$349,572
Previous $140,000 154.29%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$5.11 - $9.46 $185,733 - $343,842
36,347 Added 124.84%
65,463 $356,000
Q2 2024

Jul 31, 2024

SELL
$2.87 - $9.1 $36,572 - $115,961
-12,743 Reduced 30.44%
29,116 $140,000
Q1 2024

Apr 29, 2024

BUY
$2.57 - $4.84 $23,847 - $44,910
9,279 Added 28.48%
41,859 $130,000
Q4 2023

Feb 06, 2024

BUY
$1.99 - $3.12 $39,800 - $62,400
20,000 Added 158.98%
32,580 $93,000
Q3 2023

Oct 23, 2023

BUY
$2.75 - $4.48 $34,595 - $56,358
12,580 New
12,580 $37,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $550M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.